Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-01-22 @ 1:49 PM
Study NCT ID:
NCT06528769
Status:
RECRUITING
Last Update Posted:
2025-09-30
First Post:
2024-07-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Sponsor:
Gabriel Tinoco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-26
First Submit QC Date:
None
Study First Post Date:
2024-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED